176 related articles for article (PubMed ID: 34158547)
1. PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.
Ozawa N; Yokobori T; Osone K; Katayama C; Suga K; Komine C; Shibasaki Y; Shiraishi T; Okada T; Kato R; Ogawa H; Sano A; Sakai M; Sohda M; Ojima H; Miyazaki T; Motegi Y; Ide M; Yao T; Kuwano H; Shirabe K; Saeki H
Sci Rep; 2021 Jun; 11(1):13077. PubMed ID: 34158547
[TBL] [Abstract][Full Text] [Related]
2. HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis.
Okami H; Ozawa N; Sohda M; Yokobori T; Osone K; Erkhem-Ochir B; Dorjkhorloo G; Shiraishi T; Okada T; Sano A; Sakai M; Miyazaki T; Ogawa H; Yao T; Oike T; Sato H; Shirabe K; Shibata A; Saeki H
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686454
[TBL] [Abstract][Full Text] [Related]
3. Nondysplastic Ulcerative Colitis Has High Levels of the Homologous Recombination Repair Protein NUCKS1 and Low Levels of the DNA Damage Marker Gamma-H2AX.
De Angelis PM; Schjølberg AR; Hughes JB; Huitfeldt HS; Norheim Andersen S; Østvold AC
Inflamm Bowel Dis; 2018 Feb; 24(3):593-600. PubMed ID: 29462394
[TBL] [Abstract][Full Text] [Related]
4. DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells.
Sato H; Niimi A; Yasuhara T; Permata TBM; Hagiwara Y; Isono M; Nuryadi E; Sekine R; Oike T; Kakoti S; Yoshimoto Y; Held KD; Suzuki Y; Kono K; Miyagawa K; Nakano T; Shibata A
Nat Commun; 2017 Nov; 8(1):1751. PubMed ID: 29170499
[TBL] [Abstract][Full Text] [Related]
5. MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals.
Ozawa N; Yokobori T; Osone K; Bilguun EO; Okami H; Shimoda Y; Shiraishi T; Okada T; Sano A; Sakai M; Sohda M; Miyazaki T; Ide M; Ogawa H; Yao T; Oyama T; Shirabe K; Saeki H
Int J Cancer; 2024 Jan; 154(2):359-371. PubMed ID: 37676657
[TBL] [Abstract][Full Text] [Related]
6. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
7. Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer.
Sekikawa A; Fukui H; Fujii S; Nanakin A; Kanda N; Uenoyama Y; Sawabu T; Hisatsune H; Kusaka T; Ueno S; Nakase H; Seno H; Fujimori T; Chiba T
Gut; 2005 Oct; 54(10):1437-44. PubMed ID: 15914572
[TBL] [Abstract][Full Text] [Related]
8. Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma.
Smithy JW; Moore LM; Pelekanou V; Rehman J; Gaule P; Wong PF; Neumeister VM; Sznol M; Kluger HM; Rimm DL
J Immunother Cancer; 2017; 5():25. PubMed ID: 28331615
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of programmed death ligand 1 in refractory inflammatory bowel disease.
Nguyen J; Finkelman BS; Escobar D; Xue Y; Wolniak K; Pezhouh M
Hum Pathol; 2022 Aug; 126():19-27. PubMed ID: 35489437
[TBL] [Abstract][Full Text] [Related]
10. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
11. Over-Expression of Immunosuppressive Molecules, PD-L1 and PD-L2, in Ulcerative Colitis Patients.
Rajabian Z; Kalani F; Taghiloo S; Tehrani M; Rafiei A; Hosseini-Khah Z; Hosseini V; Ajami A
Iran J Immunol; 2019 Mar; 16(1):62-70. PubMed ID: 30864556
[TBL] [Abstract][Full Text] [Related]
12. Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step.
Tanaka T; Kobunai T; Yamamoto Y; Emoto S; Murono K; Kaneko M; Sasaki K; Otani K; Nishikawa T; Kawai K; Hata K; Nozawa H; Watanabe T
Cancer Genomics Proteomics; 2017; 14(5):341-348. PubMed ID: 28871001
[TBL] [Abstract][Full Text] [Related]
13. Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-Associated Neoplasia.
Frick A; Khare V; Paul G; Lang M; Ferk F; Knasmüller S; Beer A; Oberhuber G; Gasche C
Mol Cancer Res; 2018 Apr; 16(4):634-642. PubMed ID: 29378905
[TBL] [Abstract][Full Text] [Related]
14. γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma.
Sakurai E; Ishizawa H; Kiriyama Y; Michiba A; Hoshikawa Y; Tsukamoto T
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743122
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous microsatellite instability observed within epithelium of ulcerative colitis.
Ozaki K; Nagasaka T; Notohara K; Kambara T; Takeda M; Sasamoto H; Jass JR; Tanaka N; Matsubara N
Int J Cancer; 2006 Dec; 119(11):2513-9. PubMed ID: 16929496
[TBL] [Abstract][Full Text] [Related]
17. Status of Gene Methylation and Polymorphism in Different Courses of Ulcerative Colitis and Their Comparison with Sporadic Colorectal Cancer.
Liu C; Yuan ZY; Yuan H; Wu KX; Cao B; Ren KY; Cui MJ; Liu JH; Chen HX; Pang YW
Inflamm Bowel Dis; 2021 Mar; 27(4):522-529. PubMed ID: 32793962
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
Gui X; Liu S; Yan Y; Gao Z
World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
[TBL] [Abstract][Full Text] [Related]
20. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
